WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2012114317) NOVEL REBAMIPIDE COMPLEXES AND COCRYSTALS
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2012/114317    International Application No.:    PCT/IB2012/050871
Publication Date: 30.08.2012 International Filing Date: 24.02.2012
IPC:
C07D 215/227 (2006.01), A61K 31/4353 (2006.01), A61P 1/04 (2006.01)
Applicants: NUFORMIX LIMITED [GB/GB]; Cowley Road Edinburgh House St. Johns Innovation Park Cambridge Cambridgeshire CB4 0DS (GB).
HOLLAND, Joanne [GB/GB]; (GB) (For US Only).
GOODING, Daniel [GB/GB]; (GB) (For US Only).
CHORLTON, Alan [GB/GB]; (GB) (For US Only)
Inventors: HOLLAND, Joanne; (GB).
GOODING, Daniel; (GB).
CHORLTON, Alan; (GB)
Priority Data:
61/446,573 25.02.2011 US
Title (EN) NOVEL REBAMIPIDE COMPLEXES AND COCRYSTALS
(FR) NOUVEAUX COMPLEXES DE RÉBAMIPIDE ET CO-CRISTAUX
Abstract: front page image
(EN)New rebamipide complexes and new rebamipide cocrystals are disclosed, specifically a 1:1 rebamipide nicotinamide complex, a 1:1 rebamipide nicotinamide cocrystal, a 1:1 rebamipide 2,4- dihydroxybenzolc acid complex, and a 1:1 rebamipide 2,4-dihydroxvbenzoic acid cocrystal. Pharmaceutical compositions containing a rebamipide complex or cocrystal of the invention and a pharmaceutically acceptable carrier and methods of treatment are also disclosed.
(FR)L'invention concerne de nouveaux complexes et de nouveaux co-cristaux de rébamipide, et plus spécifiquement un complexe de 1:1 rebamipide nicotinamide, un co-cristal de 1:1 rebamipide nicotinamide, un complexe d'acide 1:1 rebamipide 2,4- dihydroxybenzoïque et un co-cristal d'acide 1:1 rebamipide 2,4-dihydroxybenzoïque. L'invention concerne des compositions pharmaceutiques contenant le complexe ou le co-cristal de rébamipide de l'invention, un excipient pharmaceutiquement acceptable et des méthodes de traitement.
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KN, KP, KR, KZ, LA, LC, LK, LR, LS, LT, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)